ATLANTA , July 23, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), Â a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2026 financial...
3 Reasons to Sell AORT and 1 Stock to Buy Instead
3 Stocks Under $50 with Warning Signs
2 Growth Stocks Set to Flourishand 1 We Ignore
ATLANTA , June 29, 2026 /PRNewswire/ --Â Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that the U.S. Food and Drug Administration...
3 Profitable Stocks We Keep Off Our Radar
1 of Wall Street’s Favorite Stocks with Solid Fundamentals and 2 We Question
ATLANTA , June 10, 2026 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate at the...
Q1 Earnings Outperformers: Artivion (NYSE:AORT) And The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks
3 High-Flying Stocks Walking a Fine Line